13 full members confirmed on global panel with expertise covering the
entire pharmaceutical supply chain
New panel members:
Vijay Shah, COO at Piramal Enterprises and pharma business lead
Mark Carver, Senior Vice President, Research, Development & Innovation
at Fujifilm Diosynth
Sam Venugopal, Director in the Healthcare Practice at PWC
William Botha, Consultant and Founder Interlean
Prabir Basu, former Executive Director at NIPTE
Emil Ciurczak, expert on spectroscopy and PAT
Dilip G Shah, CEO of Vision Consulting Group
AMSTERDAM, July 16, 2013 /CNW/ - CPhI Worldwide, organised by UBM Live, and CPhI Pharma Evolution have announced its full expert industry
panel list ahead of the publication of a forward looking annual report
(due out in September) examining future contingencies for the
pharmaceutical industry. Additionally, the panel has also contributed
to the first CPhI Pharma Evolution monthly report due out imminently
[within the next week] examining the current trends in 'formulation and
ingredients'- such as issues relating to growth of the market,
development of tablets, QbD, PAT, bioavailability, outsourcing,
dissolution and stability.
Each panel member has been individually chosen following an exhaustive
selection process involving industry peers and journalists to ensure
that the panel has the appropriate expertise to independently and
holistically examine global trends. In total, CPhI now has 13 world
renowned experts, covering the entire pharmaceutical supply chain from
R&D through to finished products, regulatory requirements and economic
The new panel members will provide a depth of experience and features
experts from some of most innovative players in the pharmaceutical
sector- including pioneers like Fujifilm Diosynth and Piramal.
Featured on the panel will be Piramal's pharma sector lead - spanning
three divisions Pharma Solutions, Critical Care and Lab Diagnostics -
Vijay Shah who has over two decades of experience and has overseen many
business transformations. The Indian giant Piramal is transitioning
from its traditional roots in contract and generics manufacturing
towards the development of new chemical entities. This step change
approach has marked a seismic shift from West to East, as increasingly
companies like Piramal start to challenge the traditional big pharma
developers of drugs, and crucially, begin to sell IP protected products
into western markets. Vijay will leverage his perspectives on breaking
through the patent cliff and the development of Antibody Drug
Joining Mr Shah will be PWC's Director of healthcare practice, Sam
Venugopal who has over 15-years' experience across biotechnology and
pharmaceuticals with expertise that span quality systems, regulatory
compliance and supply chain activities- including working with the FDA
on improving its own quality systems.
Mark Carver, Senior Vice President, Research, Development & Innovation
at Fujifilm Diosynth also joins the panel and will bring a wealth of
experience in the development of innovative technologies particularly
in relation to scalable and validated manufacturing processes. His
industry acumen and knowledge spans 20-years of work on recombinant
protein products based on microbial expression in bacterial, yeast and
filamentous fungal systems.
Another expert across R&D and drug manufacturing, Prabir Basu, formerly
of the National Institute for Pharmaceutical Technology and Education
(NIPTE), will direct the panel's attention towards how the industry can
look to increase innovation. As the development of new compounds come
to market it is important that development and manufacturing techniques
keep pace with the changing landscape of drug targets. He has spent the
last 10-years heading the NIPTE and is a renowned expert in looking at
the future challenges in drug manufacturing and R&D.
Secretary-General of the Indian Pharmaceutical Alliance and an expert on
the Indian and worldwide regulatory landscape, Dilip Shah will provide
insights into the future landscape and implications for pharmaceutical
companies of potential changes. His experience spans over 45-years and
through his consultancy practice (Vision) he works with some of the
world's leading companies looking at strategic planning.
Emil Ciurczak provides an extensive range of pharmaceutical acumen
across spectroscopy, PAT and QbD, having introduced NIR Spectroscopy
consulting and written over 200 technical papers. He has also
previously been a member of the FDA's PAT committee and is currently
president of Doramaxx Consulting. The panel will be completed by William Botha, a respected trainer and
mentor in manufacturing. He is fluent in FDA regulations, including GDP
and GMP and has taught an aseptic processing course for PDA and a
Quality Systems course for AAMI.
For the duration of 2013 members of the panel will take part in CPhI
short monthly reports - entitled 'CPhI Pharma insight series' -
examining topical issues across a total of eight broad themes: Drug Delivery; Formulation & Ingredients; R&D; Manufacturing; Packaging
& Distribution; Regulatory Compliance; Contract Services & Supply Chain
Management; and QA/QC.
The ultimate goal of the panel's inception is to utilise their
respective areas of expertise to scrutinize how the industry will
change across the coming 5-10 years in an annual report. The report
will feature a mixture of primary industry data (industry surveys) and
the collection of in depth essays from each panel member- with experts
given carte blanche to prophesize how the industry will look and operate in the future from
both an economic and practical perspective.
"Our panel provides a tremendous picture of all areas of the
pharmaceutical value chain and, just as importantly, from different
global perspectives. Collectively, our panel has hundreds of years of
senior level expertise and they have been responsible for some of the
industry's most innovative development and changes over the last 30
years. This knowledge gives them the depth of understanding that allows
them provide an unrivalled picture of how the industry is predicted to
change," commented Chris Kilbee, Brand Director, Pharma at CPhI.
For more information, please contact: email@example.com
CPhI drives growth and innovation at every step of the global
pharmaceutical supply chain from drug discovery to finished dosage.
Through exhibitions, conferences and online communities, CPhI brings
together more than 100,000 pharmaceutical professionals each year to
network, identify business opportunities and expand the global market.
CPhI hosts events in Europe, China, India, Japan, Southeast Asia,
Russia and South America and co-locates with ICSE for contract
services, P-MEC for machinery, equipment & technology, InnoPack for
pharmaceutical packaging and BioPh for biopharma. CPhI provides an
online buyer & supplier directory at CPhI-Online.com and hosts a global
community with news and analysis at PharmaEvolution.com, produced by
UBM Live and partners.
For more information visit: http://www.cphi.com
About CPhI Pharma Evolution
CPhI Pharma Evolution (http://www.pharmaevolution.com) launched in February 2013 as a global online community where
professionals from across the pharmaceutical manufacturing sector can
talk with their peers and share best-practices and regulatory updates
across the pharmaceutical ingredient and contract manufacturing space.
Pharma Evolution is the new go-to community for industry professionals
to exchange thoughts and network on key areas including: formulation,
APIs, excipients, drug delivery, R&D, manufacturing and quality,
packaging and anti-counterfeiting, regulatory compliance, and
outsourcing and supply chain management. Pharma Evolution was created
as an extension of CPhI's global events business as a forum and
resource for pharmaceutical executives to employ 365 days a year.
Pharma Evolution is published by CPhI and UBM DeusM
(http://www.deusm.com), the marketing services division of UBM
specializing in building and operating highly engaged communities of
qualified users within specialist B2B markets, using a strategy of
best-practices focused on content and technology.
About UBM Live
UBM Live connects people and creates opportunities for companies across
five continents to develop new business, meet customers, launch new
products, promote their brands, and expand their market. Through
premier brands such as TFM&A, Internet World, IFSEC, MD&M, CPhI, Cruise
Shipping Miami, the Concrete Show, and many others, UBM Live
exhibitions, conferences, awards programs, publications, Websites, and
training and certification programs are an integral part of the
marketing plans of companies across more than 20 industry sectors.
SOURCE: UBM Live
For further information:
For media enquiries, please contact:
Alex Heeley or Tristan Jervis
De Facto Communications
T: +44-207-203-6745 / 6740
E: firstname.lastname@example.org / email@example.com